Catalyst Wire Dossier Catalyst Wire Dossier

IBSRELA

tenapanor hydrochloride · Ardelyx, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for IBSRELA, covering 2019-09-12 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation [Phase 4]

See pricing